0 likes | 0 Views
The rising prevalence of infectious diseases among animals and increasing incidences of human infections are the major factors driving the market growth. According to the Centers for Disease Control and Prevention (CDC) report, enteric diseases linked to animals or environments account for 450,000 cases of illnesses, 5,000 hospitalizations, and 76 deaths among humans in the US alone.
E N D
Market Size The ELISA diagnostic test market size is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030.
Key Segmentation • By Adoption • Human and Veterinary • By Test Type • Sandwich ELISA • Indirect ELISA • Competitive ELISA • Multiple & Portable ELISA • By Application • Autoimmune Diseases • Infectious Diseases • Cancer Diagnosis • Protein Quantification • By End User • Hospitals & Diagnostic Centers • Pharmaceutical & Biotechnology Companies • Veterinary Hospitals & Diagnostic Laboratories
Key Players • Bio-Rad Laboratories Inc • Idexx Laboratories Inc • F. Hoffmann-La Roche Ltd • Thermo Fisher Scientific Inc • Abbott Laboratories • Danaher Corp • Innovative Diagnostics • Pictor Ltd • DiaSorin SpA • Elabscience Biotechnology Inc